text:
Top 5 Unique and Fulfilling Healthcare JobsNovember 14, 2012
By Health eCareers
Don't think of allied healthcare careers as "health jobs for those who couldn't become doctors;" these vital, in-demand careers are more than just support roles. The Bureau of Labor Statistics projects that by 2020, healthcare will generate nearly 5.6 million new jobs--more jobs than any other sector of the economy--largely because of the number of allied jobs added.
1. Pharmacy Technician (CPhT)
This is an unusual job because most patients don't know it exists--but the folks in white coats who usually help you with your prescriptions aren't just cashiers, nor are they pharmacists. Technicians know uses, generics, and calculations for the most common drugs. They transcribe prescriptions from doctors, manage health insurance, and prepare medicines. Solving insurance problems or helping manage a patient's medicine takes patience and mental agility--making this healthcare career both intellectually stimulating and fulfilling from a people-care standpoint. Because many employers provide on-the-job training and certification, this is a good place to begin a healthcare job search.
2. ABA Autism Therapist
This healthcare job takes place in quiet offices hidden away from the hustle-and-bustle of a normal hospital setting--again, most people don't know this healthcare job exists. The only scientifically-proven autism therapy, ABA, or Applied Behavior Analysis, has more than 28 research studies to back it up. Through patient repetitions and meticulous data-keeping, therapists help children with autistic disorders transform from silent sufferers into healthy kids. If we can think of a child's doctor as the 'General,' then these are the soldiers, the boots on the ground that actually make healing happen.
The unusual physical demands make this healthcare job ideal for younger applicants: therapists must be patient and able to crawl around on the floor with a child. Therapists can intern and undergo training on the job at an autism center while, after, or before earning a certification at a 4-year college. It's a convenient candidate for your healthcare job search because therapists can receive pay while in school, but more importantly, it's fulfilling because sometimes when no one else understands a child, an ABA therapist will.
3. Massage Therapist
This healthcare career's possible locations make it unusual: a massage therapist could work on a cruise ship, out of a home residence, at a spa, or any place where the therapist can set up a table. Also unique to this job--and part of what makes it so fulfilling--is the high amount of intimate and caring patient interaction. Everyone knows that a good massage therapist can radically change patient well-being and may become a trusted friend; everyone does not know that massages can increase blood flow to break down scar tissue, remove skin toxins, and help repair injuries. This healthcare job requires about a year of schooling; many community colleges offer courses, but many applicants choose to apply to a focused massage school such as the Virginia School of Massage or the Hawaii Massage Academy.
4. Patient Educator
This job is definitely unique to our modern era, and because it's a new phenomenon, not all applicants know to include it in their healthcare job search. With current doctor shortages, many physicians do not have time to answer all a patient's basic questions; a patient educator steps into the fulfilling role of knowledge-source and go-between so that patients receive all the information they need.
While most patient educator positions require a nursing degree, training depends on the hospital: many employers provide training as long as the applicant can demonstrate professionalism and ability to learn. Some employers may even train educators with only a high-school diploma.
5. Nutritionist
As an old Chinese proverb says "let your food be your medicine." According to the BLS, dieticians and nutritionists can earn as much as $50,000 a year, with a 20 percent projected increase in the number of future jobs available. Many applicants see this job as unusual or "alternative" because nutritionists manage patient care with less focus on medications or procedures, and more focus on natural, holistic health solutions. There's almost nothing more fulfilling than improving a patient's well-being with such minimal invasiveness. Finally, because this healthcare job requires at least a bachelor's and often a master's, many nutritionists find the education experience alone empowering--what's better than a job that teaches applicants to minimize their own healthcare costs?
These unique healthcare jobs make up only a small sector of the allied health professions, and as the field continues to grow, applicants can expect the type of jobs available to expand as well. Keep an eye out for the unusual, focus on the fulfilling, and good luck on your healthcare job search.
For more allied health career tips and jobs, visit the allied health career center.


text:
Started this discussion. Last reply by archaeopteryx Jul 29, 2012. 12 Replies 0 Likes
Hi all -I am an atheist and my husband is an agnostic - we have 2 boys, 6 and 3. His parents live in the same town and are extremely active in their church, which is a pretty mild Presbyterian…Continue
Guinevere McIntyre has not received any gifts yet

subset: commoncrawl


text:
Site Terms of Use
The Website is an Internet property of Change That Up (CTU) DBA Golf Game Focus ("CTU," "we" or "us"). You agree to the following Website Terms of Use in their entirety, when you: (1) access or use the Website; and/or (2) purchase products or services offered on our Website ("Online Products"). The Privacy Policy ("Privacy Policy") and any and all other applicable CTU operating rules, policies, price schedules and other supplemental terms and conditions or documents that may be published from time to time, are expressly incorporated herein by reference (collectively, the "Agreement"). Please review the Agreement carefully. If you do not agree to the terms and conditions contained within the Agreement in its entirety, you are not authorized to use the Website in any manner or form whatsoever.
This Agreement and any operating rules for the CTU Sites established by CTU constitute the entire agreement of the parties with respect to the subject matter hereof, and supersede all previous written or oral agreements between the parties with respect to such subject matter. This Agreement shall be construed in accordance with the laws of the State of Arizona without regard to its conflict of laws rules. Any dispute arising under or relating to this Agreement or any CTU Site shall be brought in state or federal courts in Scottsdale, Arizona, and you hereby irrevocably consent to the jurisdiction of such courts. No waiver by either party of any breach or default hereunder shall be deemed to be a waiver of any preceding or subsequent breach or default. You also give full permission to CTU to charge other accounts provided on items purchased and not paid for. The section headings used herein are for convenience only and shall not be given any legal import.


text:
By now you've probably heard about Japanese venues where women cater to male customers. But it's a two-way street, and in Tokyo, female tourists can head to the red light district and one of the city's many "Host Clubs."
The practice of men paying to make women feel good is not new, but it's gone increasingly mainstream in recent years. The latest dispatch comes via the Huffington Post. Host clubs are popular, says the owner of one booming chain, with "ladies dissatisfied with relationships...the hosts entertain them. They listen, and make them feel special." And it doesn't come cheap: a popular host cited in the article nets some 300,000 yen a month. According to some reports, some women have gone broke sustaining the illusion of romance. And as the documentary The Great Happiness Space (excerpted above) explores, many of the women are sex workers themselves, looking for a break from reality. Host clubs, like their female counterparts, don't explicitly involve sex, although often "paid dates" can be arranged. It's an obvious evolution of the geisha concept — 21st century style.
But it's not always show: a host tells the HuffPo that one regular client "ended up leaving her boyfriend to marry him."
Manabu Numata: Chronicling Tokyo's Host Clubs [CNNGo]
Rent Boys [Time]
The World's Gaudiest Japanese Host Club: Shinjuku Ai [Huffington Post]


text:
Like bikes? Like maps? You'll like this. Like bikes? Like lazy tv journalism? You'll like this. Like bikes? Like Mallomars? I think they're just ok. I was surprised to learn that you can purchase Mallomars through amazon.com and I was pleased to see that they did not garner even one one-star review. They, a box of cookies mind you, did receive this two-star review:
Although this item did taste okay, the real fact is one 8 ounce package is only 18 cookies. I thought this was overpriced and not a good value. I will not be purchasing this again.
Currently, a pack of 3 8 oz. boxes retails for $23 (!). Thus concludes the first-ever edition of Tales From the Mallomarrows. (When said in the voice of the priest from Princess Bride, "mallomarrows" sounds like the name of a county in historical Hungary)
Well, this post seems to have gone off the rails earlier than usual.
I followed East Capitol to the Capitol than Pennsylvania Avenue to
After coffee, which a jolly gathering as usual, I rode G to 18th and then picked my way past commuter buses up the little hill from Pennsylvania Avenue to K Street and down the little hill to L Street, where I crossed the cycle track. This is a very small sample size, but I can't say for sure that I've ever seen another bike commuter using the cycle track when I've ridden uptown across it. Maybe in springtime. Maybe when #mstreetcycletrack is done and people know that they'll be able to get back west.
I screwed up getting around Dupont Circle and rode counterclockwise on the sidewalk and just made a mess of the whole thing. I was unwilling to wait to cross into the circle and I should've just been more patient because the sidewalk around Dupont Circle, with it's many curb cuts and slip lanes, is not conducive in any way to bicycling.
Got a nice nasty glare from a driver who was mad that she had to pass me within a foot. I'm also sorry that there was a slow dump truck in the left lane, "forcing" you to squeeze between it and me. I wasn't overly perturbed, but as a result, I did start thinking abut cars in the city (a movie in which a computer-animated Sarah Jessica Parker finds the true means of friendship, family and expensive shoes?) and whether, if policymakers so chose (which they won't because this isn't really plausible or fair), driving could be made so painful and agonizingly awful that people would switch to another way of getting around. Basically, where's the pain threshold for car commuters? It's apparently not the high cost of gas or the current level of traffic, which is an abysmal timesuck. I concluded, during the rest of my time biking up Massachusetts at least, that I couldn't think of a "stick-only" approach to getting people out of their cars and they'd need to be won over over with carrots. Maybe I will buy a bag of baby carrots and bike out to the suburbs to see how that goes.


text:
Publisher: APCNews NEW YORK, 05 November 2013
The second meeting of the working group will take place from 6-8 November 2013. The main objective is to discuss the input by stakeholders to the questionnaire developed earlier in the year and to draft recommendations based on those answers.
Here are some relevant resources:
- WGEC page
- Analysis of the responses to the questionnaire of the WGEC
- APC's response to the questionnaire
- All the responses
- Programme
Civil society members of the WGEG are:
- Carlos A. Afonso, NUPEF Institute, Brazil
- Avri Doria, independent researcher
- Grace Githaiga, KICTANET, Kenya
- Joy Liddicoat, APC's internet rights coordinator
- Parminder Jeet Singh, IT for Change, India
APC's Joy Liddicoat (@internetrights) and Avri Doria (@avri) will be follow the discussion remotely and live tweeting about it.
Remote participation
During the time of the meeting (from 10 am to 6 pm Geneva time, GMT +1), remote participation will be available here:https://intgovforum.webex.com/intgovforum/e.php?AT=WMI&EventID=234918677&PW=NMDNhN2I3ZTkz&RT=MiMyMw%3D%3D_
Meeting password: wgec
Non-member participation
From the official website:
Due to the security regulations of the Palais des Nations and the space restrictions of the room where the second meeting of the WGEC will be held, the participation of non-member states observers will be limited to the first 20-25 organizations that express their interest in attend this event. The allocation of the places will be made on a first-come first-served basis. Consequently, we encourage the organizations interested in attend the meeting to send the information of their delegations (name and affiliation) to firstname.lastname@example.com as soon as possible.


text:
Join our live RV chat - click HERE
Anyone who is willing to die to protect me or my belongings has my thanks, and whatever they get in their retirement, in my opinion, is well earned. Thank you all.
Is the pension money put away as it is earned/paid so that it can grow and earn interest or is it being spent now with promissory notes put in for a future day of reckoning? Some states actually are putting the money into investments that grow and build a huge bankroll to support the future retirements. CA in not one of those. Is that the employees fault or the voters fault for putting politicians in charge of the funds? Ken
Sometimes the pension funds are treated like an ATM by the politicians, just as Social Security has been dipped into by our leaders, thus leading to it being inadequate and underfunded, as well as being referred to as unstable and unsustainable.The truth is, if the funds were left alone by the pols, and only used for their intended purpose, and funding schedules were adhered to, along with having money managers performing their fiduciary duties, and investing the money properly, the accounts would be fine, but they refuse to follow these very simple rules, and they have put these retirement accounts in jeopardy of collapse in the future. It's not their money, to do with as they please, so they shouldn't be touching it, and replacing the money they take out with IOUs!
A lot of truth there Rebelsun. But who is blamed? Why the retiree of course. Ken
Did that fire chief write the retirement rules? Does he hold the proverbial purse strings? Or did he find a hole in the rules that someone else wrote? If indeed he set his own salary, without a City Manager, City Council, Board of Governors, Board of Commissioners, or someone else setting the rules, then shame on him. If he does work under one of those types of systems, then we're back squarely at politicians. (Is that the City where the part time council members were making $150,000 a year too?) According to the Bureau of Labor and Statistics (http://www.bls.gov/oes/current/oes332011.htm) CA employs 30,440 firefighters in the state. Their average pay is $34.44 per hour $71,630 annually. So while there are no doubt some outliers, there are also a bunch of hard working folks. I'm not aware of any firefighter whose job requires a vow of poverty. While every taxpayer would like every public employee to have a reasonable salary, the pay should be commensurate with the risk and/or skills involved. Ken
Did that fire chief write the retirement rules?
I am not saying a public safety job is an easy job....that goodness the retirement and pay is pretty good.Rather than go through all the day after day misery and 24 hour danger of a public safety career ....I should have gotten a job at almost county/ city/ state maintenance yard and spent 30 years leaning against a shovel.
Truck drivers and construction laborers have deadlier jobs than police officers and the statistics have shown this for years, quit yer bellyaching...
Those statistics only consider on duty deaths. They do not factor in chronic injuries, stress, or job induced cancers that show up years later.
Life is full of choices, some people make good choices, and some make bad choices. It all comes down to the choice you make.
... I tell people who say "you have it made" the story of the turtle and the hare. Plod along live within your means, put money away and when you cross the finish line you will be a winner, not like the hare and rush to the finish line with nothing to show for it...
Everyone here knows at least one person who always has a new car, the latest designer fashions, the newest high tech gizmo, and not a penny in the bank.I think of it more as the grasshopper and ant story. We have become a nation of grasshoppers angry at the ants.
.....live paycheck to paycheck in their checking account, they have a small savings account valued at less than a weeks pay, and credit cards up the wazoo.
As what happened to Detroit and California, the auto industry, and the housing market it was only a surprise to the uninformed. All the indications were pointing to disaster. The rest is history. (to the uninformed, history repeats itself)
Now I do not have a crystal ball, I'm not psychic, ( have been called psycho a few times)
Gary what was the alternative to buying a house in your example? Not buying and just renting? Where would you be had you rented either or both times? Better off or worse off?
If you hadn't bought the house, you would have paid the tax and the money would be gone. A known bad outcome. And then you'd have a pile of rent receipts, another known bad outcome.
Looking at the big picture buying a house to be your home is a known good outcome, most of the time.
Ken;My brothers name. Our lives seem to run parallel. I also held a second job, (several) my bride does not believe woman should not work. Should not be dependent on spouse. After children were in school she went back to work. A second pension, it was her money.I think our choices were inspired by our parents and how they lived. As they say the "Apple does not fall far from the tree."
Page created in 0.087 seconds with 22 queries.


text:
This sleek little dongle, called Plair, is a neat little solution for slinging video from any number of devices to your TV. Simply plug it into an empty HDMI port and beam media to it via Wi-Fi.
Sure, there are plenty other ways to do that already—principally Airplay and the upcoming Miracast—but this is a perfectly neat solution, too. With custom apps for Android, iOS, OS X and Windows, it lets you throw local video, network shows or content from a raft of websites—YouTube, ESPN, NBC, Fox, and plenty more—to the TV in question. Seems particularly straightforward for people who aren't after anything too fancy.
Available in late January this year, it should cost around £60—which might well make it worth a look if you're after a simple way to stream video to your dumb TV. [Plair]


text:
The Los Angeles District Attorney's office has not yet received the case involving Aldon Smith's arrest Sunday at LAX for a fake bomb threat, and thus potential charges aren't expected to come today, according to a DA spokesman.
Smith posted $20,000 bail Sunday night some five hours after allegedly making a fake bomb threat and acting "belligerent" with airport security.
Smith is expected to appear in Santa Clara County Superior Court on April 29, regarding last season's felony weapon charges and drunken driving arrest.
The 49ers' leading sack producer since 2011, Smith is entering the final year of his rookie contract, though the 49ers have until May 3 to pick up his 2015 option at reportedly $9.75 million. The team opens its offseason training program April 21.


text: As the world's most famous eyewear brand, as well as the inventors of both the Aviator and Wayfarer sunglasses, Ray-Ban has cultivated a well-deserved reputation for trendsetting. Every frame they sell is constructed with the highest quality components. Their fresh styling, with a contemporary, yet vintage, look continually appeals to millions of loyal customers. • Official Ray-Ban Store • Made in: China • Lens Length: 52 • Bridge Size: 14 • Frame Material: Injected • Frame Color: Violet Fluo Trasp Rubber • Lens Color: Grey Mirror Violet


text:
Home >> Course Descriptions >> College of Arts and Sciences
History of Latin America
Three semester hours.
Study of both the Colonial and National Periods of Latin America. Coverage on the earlier era will extend from the indigenous peoples to the Conquest and Colonial era. In the National Period, attention will be given to the transition to independence and accompanying issues, including relations with non-Hispanic powers, to the spread of industrialization late 1800s, to the rise of Populist leaders in the 20th Century, as well as recent trends.
Home - General Information - Student Services -
Academic Undergraduate Regulations -
Undergraduate Degrees - Academic Graduate Regulations -
Graduate Degrees - Course Descriptions - Faculty -
Appendix A - Appendix B - Appendix C - Appendix D


text:
The Driver Fernando
Driving gloves with perforations on the hand and a closure with a snap wrist. Sport and chic elegance !
You want to custom your gloves ? Colorize them via "the customizable driver"
Lamb leather glove. Artisanal manufacture.
We deliver gloves in a nice flannel jacket.
An advice for maintaining your gloves? Refer to the "maintenance advice" page.


text:
Do you know how to avoid mold and water damage in your basement? If you do not, this article will tell you how to prevent mold and water damage in your basement. Read to maintain your home's value and keep… Read More
Posts Tagged 'If a floor drain is not available'
How To Protect Your Basement From Mold And Water Damage
- February 14th, 2012
- Posted in Basement Mold Prevention, Black Mold Problems, disaster restoration, mold growth prevention, Water Damage
- Tags:
Tags: bad odors, Be sure window wells are inspected for any signs of leaking as well., chalky stains, contact Advance Mold Remediation, decaying wood, Dirt flooring has a huge amount of moisture and gives off gases, Do you know how to avoid mold and water damage in your basement?, ead to maintain your home's value and keep your living conditions healthy, facebook, flooded basements, For professional help and questions on remediation, How To Avoid Mold and Water Damage In Your Basement, How To Protect Your Basement From Mold And Water Damage, If a floor drain is not available, If you do not, If you experience any of these problems, If you need to resolve mold and water damage today in your basement, If your basement has a crack or flaw in its water protection layer, It can be used for extra storage and keep you cool during hot days, It can come through both your floors and walls, Keep your basement well ventilated to keep moisture from accumulating in its interior, Make sure your basement has a floor drain and a trap installed at the lowest point of your basement floor, Moisture discovered in a basement usually enters your home through exterior sources because the moisture of the soil surrounding the basement can seep into your home, mold growth, One way to prevent moisture from damaging your basement is to not have dirt flooring in your basement, Preventing Moisture Damage, The basement can also be the birthplace of mold and water damage because of potential moisture problems, The exterior will need to be checked for where water is draining into your basement rather than away from it, The results are standing water, There needs to be an inspection for any cracks in the exterior or interior structure of you home., this article will tell you how to prevent mold and water damage in your basement, this can become a disaster for you, twitter, Water from the soil can be higher than the basement floor, water that is spilled in your basement has no way of escaping, Waterproof the outside of your walls and install a perimeter drainage system, wet insulation, you need a professional mold remediation expert to inspect your basement and your basement's surrounding area, Your basement is a valuable and useful room in your home


text:
Contributed by:
Billy E
and Billy E
Last Updated: May 09, 2016 5:35 PM
Fantasy Football University – Class III
Pre and Off-season Strategies for Keeper and Dynasty Leagues
The first thing to do in these types of leagues is to evaluate if your team is a contender, needs a few players to get there, or is a work in progress with several holes to fill. Once you figure out where you are you can figure out what you need to do and prioritize. For example, if you are a contender, you do not need to focus on rebuilding and long term planning. You can hold off on drafting younger guys, maybe even look to trade a few picks to move up and get another big contributor and forego some depth. Instead of rebuilding you are just looking for those last few holes you have that you need to fill.
If you are far from the top team in your league, you'll need to prepare to rebuild. Draft some more rookies or young players who have more potential upside, but may take time. You can grab some solid rookie RBs who are behind veterans this year, but could be the starter in a year or 2 (think Derrick Henry or Paul Perkins).
So the first key to planning your strategy is to analyze and assess where you are now, and then formulate a plan to improve. You'll also need to figure out who to keep and who to let go.
How to Decide Who to Keep
In Dynasty Leagues you retain your entire roster for the next season, while in Keeper Leagues you hold just a select few. Those decisions will hinge on the strength of your team and the age of your players. Education may be wasted on the young, but fantasy football value is not. Simply stated, if you perceive that two players have equal value, always choose the younger one. Try to add youth and pull the plug on aging superstars.
Teams that are rebuilding in this format are advised to stock up on some younger players who could break out, while contending teams with a strong core are best-suited to add quality veteran depth to solidify their club and get prepared for the long stretch of the season. The key point is that you want to keep players who are still on the way up and have plenty of mileage left on their treads.
Good starting quarterbacks are easier to find, namely since there are more to go around with most leagues starting just one. As a rule of thumb, don't keep a quarterback at the expense of a good running back or receiver (we're talking in a Keeper league where you only keep 3-6 players or so). Stud running backs generally receive a higher premium than stud receivers, so opt for the runner if you have a stud at each position and can only hold one. With Quarterbacks, unless you have one of the elite 3 or 4 QBs, you generally do not want to waste one of your valuable keeper slots on them. You will get a starting QB in your draft.
You should also try to upgrade at your thinnest position without weakening an already strong one. This point brings us to trading.
Trading For Draft Picks
The way you go about trading should also depend on where your team is, success-wise. If a fantasy owner is very strong at running back with excellent depth, then it is a good idea to trade a quality runner to fill a void at another position, like quarterback or receiver. Draft picks can also be gold, if you can land a hot rookie with stud potential.
In keeper leagues, I always have more strong talent then I can legally hold, so I try to trade some of those gems for draft picks, as the alternative of flat-out losing those excess players to free agency is not a good one. I usually am willing to overpay to get a deal done, and am always looking to "trade up". Meaning, I'm happy to give up 2 quality players for a stud. The 2 players combine for much more points than any 1 player, but I am looking to build the strongest STARTERS, so getting a stud and sacrificing a little depth is what I am almost always willing to do.
If I can't find another stud for 1 of my spots, I am fine trading for additional draft picks, you take what you can get. But the best advice to follow is to constantly build depth during the season via the waiver wire, and then use that depth to trade up for better players by offering multiple lesser-talented guys.
The key to building a Dynasty in your Fantasy Football league is to always stay active trying to improve your team. In the off season and pre season, try to unload your aging stars before they show signs that are obvious to everyone, and lean towards younger guys who are on good offenses or good teams to be your future.
I do have one other point to leave you with if this is your first year drafting a Dynasty or Keeper League…
We haven't figured out a way to incorporate a Dynasty variable into our formulas to project them differently in the C3. We also don't put out 2 sets of projections as it's just too tough, plus in reality we are projecting what we think someone could do THIS year, so it would be the same projections.
We DO have a set of Dynasty Rankings on the site, but we put them out very early in the off season (April or May) to help guys in keeper leagues. However, we don't update them nearly as often as the C3 projections, or Main Rankings on the site so don't expect to see a separate Dynasty or Keeper Cheatsheet.
The truth is any league I draft in I draft to win THIS year, so I really don't "over" play the youth aspect even in a Dynasty league if I am starting a new team. What I do do, is use that as the tie breaker if I have 2 guys in the same tier or am stuck on which of 2 to draft. In Dynasty's Ii do look for the younger guy, and with my extra roster spots, I'll take more fliers on rookies that are expected to do little immediately or who are behind veterans.
|Fantasy Football University
|Fantasy Football's 10 Commandments


text:
A Missouri Senate committee is set to review the state's numerous tax credit programs and their impact on the state budget.
The Senate Appropriations Committee scheduled a hearing Monday on tax credits before it takes up Gov. Jay Nixon's proposed budget for the 2014 fiscal year.
The 61 tax credit programs currently offered by Missouri cost the state nearly $630 million in the latest fiscal year. Last week, the Senate approved another one, with an estimated yearly cost of $3 million, to attract amateur sporting events to the state.
The panel will also hold a hearing on the Department of Economic Development's budget Monday.


text:
You can't enjoy the adventures of a martini drinking super spy without his incredibly over the top foes, many of which aim for world domination! These memorable bad guys range from the henchmen who sling metal tipped bowler hats to those with metal jaws, and the criminal masterminds who crave nothing but gold or cry tears of blood while playing poker. Join WatchMojo.com as we count down the Top 10 James Bond Villains.
Video: Top 10 James Bond Villains


text:
The old hours were Monday to Friday from 8:30 a.m. to 10:30 p.m., and on Saturday, 10:00 a.m. to 8:00 p.m..
How on earth does one do research on the weekends when there are no hours on Saturday??
But you can help change that.
Here is an email I received from Kathie Orr in June ...
Re Restricted Archives of Ontario Hours
The Archives of Ontario has moved to a wonderful new state of the art archives building. We now have the proper facilities to access and research our history but many people are unaware that with the move we now have restricted hours of operation.
We need your help.
- At the present time the hours of operation of the Archives of Ontario are 8:30 a.m. to 5:00 p.m.
- In effect this means that any Ontario taxpayer and visitor from outside the province who works fulltime and or lives at a distance not longer have access to their records.
- If we want to have evening and weekend hours we have to make our concerns known.
- We will not get the old hours of 8:15 a.m. to 10:30 p.m. Monday to Friday and 10:00 a.m. to 8:00 p.m. on Saturday back. A good compromise might be 8:30 a.m. to 8:30 p.m. Monday to Friday and Saturday 10:00 a.m. to 8:00 p.m. The benefit is that those who will visit during the extended hours will have archival staff on hand to advise and assist you them.
- Not all records are available online or will be for the foreseeable future.
- To access the full range of records to research your family you do need to visit archives for such records as estate files, Crown land records, Private Property land records, education records, divorce files, maps, and private papers such as the T. Eaton Co.
- Sign our petition
- Have your group and any other interested parties sign our petition.
- Go to the Archives of Ontario website http://www.archives.gov.on.ca/english/index.aspx
- and click on Feedback (left side of page half way down). They ask you to "Please take a few moments to send us your comments by filling in the form below." Politely request that you would like extended hours back. You fill in your email address and you will in time get a personal reply. We want to flood the Archives with requests so they can show the government the need for the extended hours.
- Contact your local MPP
- Contact information can be found at http://www.ontla.on.ca/web/members/members_current.do?locale=en
- When contacting your MPP please emphasis your use of the Archives of Ontario, its importance to the province and that these are our records and it is our right to have access to them.
- And encourage others to do the same.
Send completed petitions to
c/o Ruth Burkholder
Ste 103 -12140 Ninth Line
Stouffville ON L4A 1L2
c/o Kathie Orr
405 – 100 Maitland St
Toronto ON M4Y 1E2
As many people do not like to open emails with an attachment until they know what it is all about a second email will be sent to you with the petition attached.
Thank you
Kathie Orr
Katharine G. Orr
405 - 100 Maitland St
Toronto ON M4Y 1E2
416-944-1794 email@example.com
stay in touch with your past to ensure your future
Editor's Note: The follow-up email I received from Kathie Orr includes a copy of the petition for printing. However, since I am unable to attach it to the blog, please contact Kathie for a copy <firstname.lastname@example.com>.


text:
Ronaldo scores hat-trick as Madrid blast past Sevilla
Published: 10th February 2013 12:40 PM | Last Updated: 10th February 2013 12:40 PM | A+A A-
Cristiano Ronaldo helped Real Madrid prime its attack for its highly anticipated Champions League clash with Manchester United by scoring his 21st career hat trick in a 4-1 home win over Sevilla in the Spanish league on Saturday.
After a defensive blunder let Karim Benzema open for Madrid 18 minutes in, Ronaldo unleashed an unstoppable strike to double the advantage in the 26th. The former Manchester star then went on to find the back of the net twice more after halftime.
Ronaldo did his best to make amends for his own goal that cost Madrid a loss at Granada in the last round with his 22nd, 23rd and 24th goals in the league this season. Only Barcelona's Lionel Messi, with 34, has scored more.
Madrid stayed in third place. It trails Barcelona by 13 points before the leader hosts Getafe on Sunday.
With Madrid's Spanish league title defense all but mathematically impossible, a large share of its silverware hopes this season now rest on its round-of-16 Champions League tie with United starting in the Spanish capital on Wednesday.
"For Madrid every game is special, but on Wednesday we have to be ready to meet the challenge," said Madrid defender Pepe, who went on late for his first action since surgery on his right ankle in early January.
"Cristiano is playing well. He is working hard and we need him to keep it up."
Also, substitute Nelson Valdez scored in stoppage time to give Valencia a 1-0 win at Celta Vigo just three days before its Champions League series with Paris Saint-Germain.
Apparently with the English challengers in mind, Madrid coach Jose Mourinho left Xabi Alonso off his squad and fellow first-choice midfielders Mesut Oezil and Sami Khedira on the bench.
Instead, sparingly used Kaka got his first start since Dec. 4.
Madrid eased in front when Benzema was well positioned to take full advantage of a miscue by Sevilla's defense. Sevilla goalkeeper Antonio "Beto" Bastos deflected Ronaldo's low cross off teammate Fernando Navarro, and the ball fell for the France striker to nudge it over the goal-line.
Madrid kept the pressure on and Ronaldo made it 2-0 when he shimmied around Sevilla midfielder Hedwiges Maduro, put the ball on his left foot, and let loose a dipping shot from beyond the area that struck the net just inside the far upright.
Barely 30 seconds into the second half, Ronaldo made Sevilla defender Federico Fazio pay dearly for his sluggish response to reach a pass as he beat him to the ball and fired under the helpless Beto.
Ronaldo wasn't done and finished off a counterattack in the 59th that he had started from near his own area, racing forward to tap in Gonzalo Higuain's cross.
Four minutes after recording his 20th hat trick for Madrid — he scored one for Manchester — Ronaldo was substituted to a standing ovation by the Santiago Bernabeu crowd.
Higuain left Madrid with 10 men from the 66th after he picked up his second yellow card. Maduro followed suit for Sevilla in the 81st.
Manu del Moral got Sevilla's consolation goal in the 87th.
Earlier, Celta was clinging to a scoreless draw before Valdez went on in the 89th. Three minutes later the Paraguay striker maneuvered free to head Joao Pereira's cross into the net at the far post and claim Valencia's dramatic victory.
Valencia, which moved into fifth place, hosts Paris Saint-Germain on Tuesday in the first leg of their round-of-16 Champions League tie.
"The game was heading to a 0-0 draw, it was a cruel result for Celta," said Valencia coach Ernesto Valverde. "In the second half the game tilted more and more to our favor, and we were just lacking that last pass."
Elsewhere, Francisco "Isco" Alarcon netted two times to lead Malaga back to a 2-1 victory at Levante, while defender Geromel also scored after 90 minutes to give Mallorca a 1-1 draw with Osasuna and salvage coach Gregorio Manzano's return.
Malaga's second consecutive away win kept it in fourth place and in control of Spain's final Champions League spot thanks to the two-goal effort from the 20-year-old Isco, who made his international debut for Spain on Wednesday.
Manzano began his third stint with Mallorca on Tuesday when he replaced the fired Joaquin Caparros. Mallorca is in second-to-last place after just one win in its last 18 games.
Granada kept Deportivo La Coruna in last place with a 3-0 win at Riazor.
Also on Sunday, second-place Atletico Madrid visits crosstown rival Rayo Vallecano nine points behind Barcelona. Real Zaragoza hosts Real Sociedad, and Espanyol is at Athletic Bilbao. Valladolid visits Real Betis on Monday.


text:
The latest edition of my WRITE-A-STORY series has a spooky theme!
These handy little printable packets will give you all the pages you need for a week of writing!
It is imperative that you allow enough quality time to model each stage of this writing process with your students.
Essentially 'modelling' is where you pretend you are the learner and show the students how to do something - in this case - write. You will verbalise each thought you have and demonstrate the strategies you use to work through a task.
The packet has a 'word helper' page that you can use to springboard your planning-stage 'brainstorm'. I highly encourage you to immerse your students in loads of pictures, charts and story books on the topic you are trying to encourage and give your students oodles of ideas and vocabulary before you ask them to brainstorm and plan.
Once you have discussed, drawn and talked about lots of 'spooky ideas' (encourage chat between your students and the pooling of ideas), show them how to complete the planning page. There are NO RULES! Let them draw, doodle, write words, scratch out, change, edit etc. Have plenty of copies on hand in case they want to 'start again'. Remember, no author gets it correct from the beginning, so encourage change and editing as they go.
Model the drafting phase when most of your students have finished their plan. One of the lined options I have provided has well spaced out lines, to allow for changes in sentences and spelling. Encourage the draft to be edited and re-written. Again, provided additional pages for longer writing.
Once your students have edited, they can publish. Show them how to do a fancy-lettered heading and write in their best handwriting.
It is a lengthy procedure to model, but I assure you that it will pay off - your students will internalise the process and quickly start to produce better quality writing!
Thanks so much for stopping by today, have a great week!


text:
830 South 9th Street, Louisville, KY 40203 - (502) 857-8496
A place for Station Park Honda Staff to place sale items, used/new motorcycles, and other products available for purchase.
Use this control to limit the display of threads to those newer than the specified time frame.
Allows you to choose the data by which the thread list will be sorted.
Order threads in...
Note: when sorting by date, 'descending order' will show the newest results first.
Forum Rules


text:
Dear Dave,
My daughter is 14, and she was recently offered a steady weekend modeling job. Do you have any advice on how to handle the money she earns?
Dear Cynthia,
In terms of investing some of the money she�ll make, a Roth IRA would be pretty cool. You would have to oversee it, of course, and you�d have to file a tax return, but starting something like this when she�s 14 would help set her up for some serious money later.
I think the biggest thing, however, is to make sure you create lots of teachable moments for this young lady. There are three areas every child should learn about when it comes to finances: spending, saving and giving. If she�s working and earning money, she should be able to spend a little and enjoy the fruits of her labors�within reason, of course.
Saving for the short term might include putting money aside for a car or even college. Long-term goals would include the Roth IRA, so she would have a head start on being able to retire with some dignity one day. Then you should always make sure to give some. Whether it�s tithing to your church or finding other good causes, giving helps others and it�s good for the giver. When we give, it helps us realize that we�re not the center of the universe. It also makes us a little more Christlike.
This is a phenomenal opportunity for your daughter. It�s also a great chance for you, as a parent, to involve her in the process and teach her important lessons that will last a lifetime!
Trusting in the family
Dear Dave,
When should a couple think about creating a family trust?
Dear Angie,
A family trust can take different shapes. Couples with young kids sometimes consider creating a trust in the event that they both die unexpectedly. In these situations, a family trust would be managed for the care of minor children.
Some people also create trusts for the purpose of avoiding estate taxes. These trusts aren�t as common, because you don�t have to worry about estate tax problems unless you have assets in excess of $5 million, based on current law.
But to be honest, Angie, I can�t think of a situation where you�d want to create a family trust to manage money while you�re alive. Unless, of course, it contains some kind of estate planning implications.
*Dave Ramsey is America�s trusted voice on money and business. He�s authored four New York Timesbest-selling books: Financial Peace, More Than Enough, The Total Money Makeover andEntreLeadership.The Dave Ramsey Show is heard by more than 6 million listeners each week on more than 500 radio stations. Follow Dave on Twitter at @DaveRamsey and on the web at daveramsey.com.


text:
University at Albany Inaugurates Robert J. Jones as its 19th President
New Chief Executive Declares Four Priorities for UAlbany
New Chief Executive Declares Four Priorities for UAlbany
President Robert J. Jones chats with UAlbany students last Februrary, one month after assuming the leadership of the University.
ALBANY, N.Y. (September 28, 2013) — For the 19th time since its founding in 1844, the University at Albany has inaugurated a new president. Today, Robert J. Jones, Ph.D., was formally installed as president at a ceremony in the University's Performing Arts Center. In his inaugural address before a packed theater of students, faculty, staff, alumni, and community and business leaders, President Jones outlined his vision for UAlbany.
"My goal is for UAlbany to become the university of choice for high school juniors and seniors. And not just those thinking about SUNY, but also major research universities across the country and around the world," Jones said.
He explained UAlbany would achieve this goal by focusing on four key priorities:
- Expand degree-granting programs to include areas such as engineering, big data analytics, and allied health sciences to meet demands in high-growth, high-needs areas.
- Increase recruitment of out-of-state and international students to ensure the diversity of perspectives that equips students to succeed in today's global society.
- Deepen the University's engagement with the Capital Region, New York State and the world, forging partnerships to solve society's most pressing issues.
- Strengthen the University's financial resources, tripling external funding for cutting-edge research, and doubling the University at Albany Foundation's endowment through gifts from alumni, parents, and friends that support students, faculty, and academic programs.
During his address, Jones lauded Governor Andrew Cuomo for advancing two key initiatives, NYSUNY 2020 and START-UP NY. The University's NYSUNY 2020 plan, approved by the Governor in December 2012, represents the largest expansion of UAlbany's capacity in decades. The plan adds 187 new faculty members over the next five years—a 30 percent increase in educators and researchers in cutting-edge fields. START-UP NY will attract businesses from across the nation and around the globe by offering opportunities to operate tax-free while collaborating with world-class researchers at SUNY institutions.
Jones called UAlbany "the best kept secret in all of higher education" and asked students, parents, alumni and friends to help tell the University's story. He emphasized the institution's momentum, citing recent milestones such as:
- A new $64 million School of Business building that provides students with a state-of-the-art learning environment;
- A new four-year undergraduate degree program in digital forensics—the first of its kind in New York and only the third in the nation—that will leverage the expertise of several of the University's colleges to create the nation's cyber-security leaders;
- A new home for The RNA Institute, an open-source biomedical technology facility that makes UAlbany an international leader in the design of RNA technologies and drug therapies for the treatment of cancer, Alzheimer's, and HIV/AIDS; and
- A long-awaited multi-sports complex featuring a stadium, track & field facility, and Bob Ford Field, which drew more than 10,000 fans to its opening football game.
In honor of President Jones and his wife, Dr. Lynn Hassan Jones, the Board of Directors of The University at Albany Foundation has created the Robert J. Jones and Lynn Hassan Jones Inaugural Scholarship Fund, with the goal of building the fund to $1 million. At a pre-inauguration dinner that served as a fundraiser for student scholarships, President Jones announced that he and Dr. Hassan Jones would donate $100,000 to the fund.
The pledge pays tribute to the long road that brought Jones from a boyhood on a sharecroppers' farm in Georgia to his new calling as the 19th president of the University at Albany. The same road took Jones from a Ph.D. in plant physiology, to a life as a faculty member and researcher, to a role as a facilitator in Nobel Laureate Archbishop Desmond Tutu's South African Education Program, and to key leadership positions at the University of Minnesota. President and Dr. Jones hope their donation will spark additional gifts to provide critical scholarship support for deserving students.
The inauguration of President Jones capped off Celebrate & Advance, a week-long series of events designed to honor the University's past while advancing plans for its future. The diverse roster included a presentation by the activist daughters of Desmond Tutu, a performance by Broadway star Carolee Carmello '83, a reading by Pulitzer Prize-winning writer Gilbert King, a panel discussion with key Obama campaign advisors David Axelrod, David Plouffe, and Jon Favreau, plus events highlighting research and scholarship, academic and campus life, diversity, and community engagement and humanitarianism.
For Celebrate & Advance highlights, including video, photos, and presidential remarks, please visit the UAlbany Inauguration Wrap-Up.
About Robert J. Jones
Robert J. Jones, who was appointed UAlbany's 19th president in November 2012 after a nationwide search, took office in January 2013. He previously served as senior vice president for academic administration at the University of Minnesota System. Prior to that, President Jones spent more than 15 years in key administrative leadership positions at the University of Minnesota-Twin Cities, including vice president and executive vice provost for faculty and academic programs; vice provost for faculty and academic personnel; and president of the University of Minnesota Outreach, Research and Education (UMore) Park Development, LLC.
A native of Dawson, Georgia, President Jones has more than three decades of higher education leadership experience as well as academic expertise spanning plant physiology and urban and international development. He earned his graduate degree in crop physiology from the University of Georgia, and a doctorate from the University of Missouri, Columbia. He is an internationally recognized authority on plant physiology and has published numerous scientific papers, manuscripts and abstracts. During the course of his career, he has trained and mentored many students who have gone on to leading careers in higher education and the private and not-for-profit sectors.
President Jones currently serves as Regional Council Co-Chair for the Capital Region Economic Development Council (CREDC). He has been a visiting professor and featured speaker in North America, Europe, Asia and Africa, and from 1984 to 1994 served as an academic and scientific consultant for Archbishop Desmond Tutu's South African Education Program. In 2010, he was awarded a University of Minnesota endowed chair in urban and international development; he was also named a recipient of the Michael P. Malone International Leadership Award by the Association of Public and Land-Grant Universities (APLU).
For more news, subscribe to UAlbany's RSS headline feeds
About the University at Albany
A comprehensive public research university, the University at Albany offers more than 120 undergraduate majors and minors and 125 master's, doctoral, and graduate certificate programs. UAlbany is a leader among all New York State colleges and universities in such diverse fields as atmospheric and environmental sciences, business, criminal justice, emergency preparedness, engineering and applied sciences, informatics, public administration, social welfare, and sociology taught by an extensive roster of faculty experts. It also offers expanded academic and research opportunities for students through an affiliation with Albany Law School. With a curriculum enhanced by 600 study-abroad opportunities, UAlbany launches great careers.


text:
Elemer Piros: The core philosophy of Steve Burrill, for the last 25 years, has been to embrace unrecognized technologies on the cutting edge in therapeutic areas such as regenerative medicine and personalized medicine. We have expanded on that by adding the research function. It's not just about the companies that are ignored; we also look at companies that have been loved in the past but have been forgotten. Perhaps there was a failure, or a series of failures in a company's history. But if we find a promising pipeline, we are willing to be open-minded.
TLSR: Are there special areas of focus?
EP: Our research encompasses these two categories: First, we look at early-stage companies where the scientific groundwork has been laid down and is solid, and second, we look at companies embracing human testing for the first time and demonstrating some indication of efficacy in treatment of a disease. Wherever we look the upside needs to be significant, because, as everyone knows, there is only a 10% chance that a drug will make it to the market once it enters a phase 1 trial. That means a 90% failure rate, unfortunately.
TLSR: Even small-cap funds can't buy micro caps in a lot of cases. Are any of the major institutional investors beginning to look at micro-cap companies as viable entities for some of their qualified investors? And what about venture capitalists (VCs) investing in micro-cap public companies?
EP: This happens on a selective basis, and usually involves specialist investors in biotech. Let me cite one very recent transactionan investment in an oncology company called MethylGene Inc. (MGY:TSX). It just closed a $26 million ($26M) round, which essentially recapitalized the company. The financing was led by Baker Bros. Advisors LLC, OrbiMed Advisors LLC, Tang Capital Partners LP, Biotechnology Value Fund and Ouray Capital. These are specialist investors in biotechnology, and they are definitely investing, even at early stages: MethylGene has a couple of compounds in phase 1/2 development for oncology indications.
"It's not just about the companies that are ignored; we also look at companies that have been loved in the past but have been forgotten."
You asked whether VC firms or some of the larger funds would embrace a slice of investment in the early stages of public biotech companies. Actually, there is an interesting trend. They are not moving en masse, but there are signs of activity, with some VC firms hiring portfolio managers whose sole focus will be on publicly traded, early-stage biotechnology. They invest $520M per company with a VC-like three- to five-year time horizon.
TLSR: Back on April 5, 2012, President Obama signed the Jumpstart Our Business Startups (JOBS) Act into law. Your firm is attempting to leverage some of the benefits of this JOBS Act. What does it mean in practice? How will it affect a startup company? More to the point, how does Burrill help companies with these new rules of eased regulatory encumbrances, restrictions and costs on small businesses?
EP: Whether we are dealing with a startup or a restart, the reduced burden of regulations, such as Sarbanes-Oxley compliance requirements, for at least a five-year period, allows these companies to invest the money they save in research and development (R&D). That is a very nice trade-off. The legislation also allows companies to enter the public markets at an earlier stage, opening access to capital from a more diversified investor base, especially when money is less available. For listed companies, liquidity is a factor for investors who don't necessarily want to stay with an investment until a trade sale or initial public offering. How can Burrill help? We have extended our scope of services to already public or newly listed companies via the JOBS Act.
TLSR: What are you looking for today in emerging life sciences companies? What features get your attention and tip you to a bullish persuasion?
EP: A solid scientific foundation is a must, a given. Also, there has to be a clearly defined, unmet medical need. In the biotech world, there are very few examples of an Apple Inc. (AAPL:NASDAQ), where we really didn't know we needed an iPad or iPad mini until the company presented one. We don't often find examples where need was actually created by a biotech company.
I also like areas that are currently ignored. It could be because of historical setbacks, an example being Novelos Therapeutics Inc. (NVLT:OTCBB) in the field of radiopharmaceuticals. Titan Pharmaceuticals Inc. (TTNP:OTC) is another example, in that the field of drug addiction is not yet recognized as a meaningful market for drug development.
TLSR: You seem to have embraced the U.S. Food and Drug Administration's (FDA) 505(b)(2) regulatory pathway, which enables companies to leverage drugs that are already in the public domain.
EP: Yes. It certainly is an easier path to follow, and companies can leverage data that were collected in phase 1, 2 and 3 trials by a previous sponsor. A specific example of a company that has been able to do this is Titan Pharmaceuticals.
TLSR: Do you get the impression that investors don't take 505(b)(2) pathway development projects quite as seriously as you think they should? Do they overlook them because these drugs seem old to them?
EP: There could be that myth or misunderstanding. At times, the difference in formulation of a drug allows for such a minute advantage that it is difficult to handicap how it would translate into a competitive edge in the marketplace. However, sometimes a reformulated product can make a dramatic difference. For instance, the opioid-addiction pill Suboxone (buprenorphine + naloxone), originally sponsored by Reckitt Benckiser Pharmaceuticals Inc. (RBGPY:OTCPK), only works if patients take it every day. If a patient takes a drug holiday, he or she relapses back into addiction. But Titan's Probuphine (buprenorphine) is reformulated in a subdermal implant. Patients can forget about it for six months and still be protected. Even if patients choose to abuse heroin during treatment, the illegal substance will not have the same impact because the protective drug is in the patient's system at all times. Here, the difference in formulation is quite vast. The new formulation addresses a key problem in addiction, which is compliance.
TLSR: Who would be the buyers of Probuphine? Would it be clinics, state health departments, departments of correction?
EP: Interestingly, the clinician would need to learn a minor surgical procedure to administer the treatment. It takes about seven to 10 minutes to implant Probuphine, a matchstick-like rod made of a flexible plastic, and it takes about five minutes to take it out after six months. Not every clinician will be willing to learn this procedure, at least at first. However, about 2530% of clinicians, according to some surveys, have indicated willingness to learn.
TLSR: You have a $4 target price on Titan, which represents an implied grand slam, a near quadruple from current levels. Is it possible that institutional buyers might negotiate the price down so far that the margins would be too thin?
EP: I think institutional buyers for the product would be in the minority, as opposed to clinicians who deal with these patients on an individual basis. Also, we haven't witnessed a large degree of price erosion with the original product, Suboxone. To many investors it appears to be a nonexistent market, but this drug actually brought in $1.2 billion ($1.2B) last year. It is far from nonexistent.
TLSR: When might we expect approval of Probuphine?
EP: Titan submitted a new drug application (NDA) at the end of October, and the FDA has 60 days to assign a Prescription Drug User Fee Act (PDUFA) date, which would be either six or 10 months from the date of submission. We should hear a decision on the drug sometime in mid-2013.
TLSR: We know this implantable technology is used in contraception. But are there other opportunities for unmet needs?
EP: Parkinson's disease is perhaps its second indication. Some encouraging animal data shows the technique is a reliable delivery mechanism for L-dopa (dihydroxyphenylalanine). Again, it's not only a convenience but also a compliance-enhancing solution. The potentials are essentially limitless. The only thing Titan needs is access to additional capital to move these programs into the clinic. The source of that capital could be a potential partnership for the commercialization of Probuphine. Just before the NDA was submitted, an unnamed partner made a down payment in the form of buying stock at a 25% premiumabout $4M worthjust to extend an option to negotiate for commercialization rights of Probuphine until Dec. 31. We should hear about the fate of that partnership before year-end.
TLSR: If you could go ahead and mention another stock that you like, I'd love to hear it.
EP: One of them is very easy to understand. Ohr Pharmaceutical Inc. (OHRP:OTCBB) is developing a squalamine eye drop for wet age-related macular degeneration (AMD). The only solutions we have right now are intravitreal injections, meaning injections into the eye, every month to two months. Those drugs are Avastin (bevacizumab; Genentech/Roche Holding AG [RHHBY:OTCQX]) (used off-label), Lucentis (ranibizumab; Genentech/Roche AG) and a newcomer, Eylea (aflibercept). This market is $4B worldwide and the new entrant, Eylea, from Regeneron Pharmaceuticals Inc. (REGN:NASDAQ), is anticipated to do $800M in sales in 2012, which will be the first full year after launch. The advantage of Eylea versus Lucentis is that it requires slightly less-frequent injections. Obviously, patients just hate the injections, as well as the time they must spend in eye exams before the very painful treatments actually occur.
"Wherever we look, the upside needs to be significant, because as everyone knows there is only a 10% chance that a drug will make it to the market."
Ohr's squalamine is in phase 2 testing, and so, on paper, we don't yet have clinical proof of concept. But that is not entirely true. An intravenous (IV) formulation of the drug was developed by a predecessor company, Geneara Corp., and it went through phase 2 clinical testing in about 200 patients. It has shown very similar efficacy as observed with Avastin and Lucentis, but is slightly less robust. However, having a weekly IV infusion at a physician's office is much more onerous for patients than a once-every-two-months injection. The predecessor company had to give up because it was in a noncompetitive situation, and it wasn't able to raise money for a phase 3 trial.
What we know now, after preclinical animal studies with squalamine as an eye drop, is that the patient is getting about six times as much drug into the retina than the dose required to inhibit neovascularization (the formation of abnormal, leaky blood vessels). This allows us to speculate that the phase 2 trial in progress will be successful. The design is very interesting. A patient is started on Lucentis and then every day, twice a day, the eye drop is given.
TLSR: Sounds like an ideal maintenance therapy.
EP: Yes. And eventually, if evidence shows Lucentis injections do not need to be given because improvement with the drops is as remarkable as it is with Lucentis, patients could start with the eye drop. But that's farther down the road.
TLSR: Squalamine is a small molecule. Could it be synthesized?
EP: Yes, the synthesis has been worked out. It's not coming from a natural source, which was the shark liver.
TLSR: Another stock you could mention?
EP: Another interesting stock is Neptune Technologies & Bioressources (NTB:TSX; NEPT:NASDAQ) and its majority-owned pharmaceutical subsidiary, Acasti Pharma Inc. (APO:TSX). This omega-3 fatty acid manufacturer up in Canada suffered a very unfortunate occurrence in early November. Its manufacturing plant in Sherbrooke, Québec, actually exploded. Acetone (highly flammable) is used to purify the omega-3s from a natural source: krill, an Antarctic crustacean. The plant was a complete loss.
It is a tragedy because lives were lost. But the company was planning to double or triple capacity over the next two to three years, and a new plant is under construction right next to the one that exploded. The company is six to nine months away from completing the new plant, so it will likely take time off from manufacturing krill oil. In the meantime, Neptune is making an attempt to find third-party manufacturing partners to continue to supply distributors with krill oil, at least to some extent. Once the plant is completed, Neptune can get back to the same level of production, which was about 150,000 kilograms per year. Its krill oil is sold as a nutraceutical (Neptune Krill Oil, or NKO).
But what's more interesting to me is a purified version of Neptune's krill oil that is being developed as a drug for hypertriglyceridemia by Acasti, a majority-owned company of Neptune's. Early clinical data indicates that this drug could potentially be as good as, if not better than, two precedent omega-3s that are already approved by the FDA. One is Lovaza (omega-3-acid ethyl esters), sold by GlaxoSmithKline (GSK:NYSE). It sells about $1B/year. The other drug is Vascepa (icosapent ethyl), which received approval during the summer and was developed by Amarin Corp. (AMRN:NASDAQ). Each of these omega-3 products has a slightly differentiated profile.
All three productsLovaza, Vascepa and the Acasti/Neptune drug CaPre (a purified extract from krill oil)lower triglycerides. Lovaza, unfortunately, produces a slight elevation of the bad cholesterol, low-density lipoprotein (LDL). That is not ideal, yet it is still a $1B drug. Vascepa, on the other hand, not only lowers triglycerides but also doesn't increase LDL. A perfect trifecta would be a drug that could lower triglycerides, increase high-density lipoprotein (HDL/good cholesterol) and decrease LDL. Early data on CaPre indicates that this might be the case.
TLSR: So the preliminary thought is that CaPre would lower LDL, in addition to lowering triglycerides and increasing HDL.
EP: That was seen in early phase 2a trials. We have to wait for additional results to underscore the effect.
It is also interesting to note that people tend to equate all omega-3s to fish oil. There was an experiment comparing regular fish oil with Neptune Krill Oil. NKO, on all parameters, was far superior to ordinary fish oil (Bunea, R. et al., Alternative Medicine Review [2004] 9:420-428; described in detail on pages 19-20 of our initiation report on Neptune). Krill oil appears to have additional ingredients, including phospholipids and an antioxidant. These are all naturally occurring; Acasti doesn't add anything to the product. It simply purifies the good stuff from the krill, which appears to make it superior to ordinary fish oil. Lovaza and Vascepa are not derived from krill.
TLSR: Is your target price still $7, following the explosion?
EP: The initiation report contained the $7 target price. We lowered the target to $6 after the company did a financing, to factor in the dilution. On Nov. 12, we updated our research and went to a Neutral rating with no target price. We have a Market Perform (Neutral) rating right now on Neptune. On the manufacturing side of the business, I would like to see more specificity and tighter timelines. I would also like to see how much of the existing customer base the company would lose if it is not able to provide product for the next six to nine months.
TLSR: Neptune says it has business interruption, property and casualty, and civil liability insurance. But this explosion and fire occurred on the afternoon of Nov. 8. I did not see anything on the company's website for days following. It was not until Nov. 12 that there was a press release from the company. I think that's a long time not to say anything about a tragedy. Three people died, and 18 people had to be hospitalized. Even if all that human tragedy didn't occur, this is still the kind of thing that you need to report as a public company. What do you think?
EP: I would have wanted to hear more earlier, because we had to rely on the media for information. It was quite obvious from pictures following the incident that the plant was gone. We didn't know whether inventory was also stored at the site, and whether this would result in a complete halt of production or if there would be some material that Neptune could sell while it was working on completing the new plant. We didn't know the extent of the damage. There were a lot of questions.
"The reduced burden of regulations (initiated with the JOBS Act) allows companies to invest the money they save into research and development."
The company defended its communication policy, saying that first and foremost it wanted to deal with the human elementthe people who perished, the 18 who were injured and their families. Between Nov. 8 and 12 the stock was halted. Since it started communicating on the 12th, and the stock finally resumed trading, Neptune has provided updates on its assessment of the damage.
I would add that, fortunately, these occurrences do not happen very frequently, and management teams just don't have the working experience to address everything on time and optimally. But I agreed with Neptune when it took care of the human element first.
TLSR: Can you mention another company?
EP: That would be Novelos Therapeutics, the radiopharmaceuticals company that I mentioned earlier. It is developing radioactive drugs, which is not a very popular sector because of a couple of commercial failures, Zevalin (ibritumomab tiuxetan; Spectrum Pharmaceuticals Inc. [SPPI:NASDAQ]) and Bexxar (tositumomab; GlaxoSmithKline). These two drugs were developed for a very narrow indication, non-Hodgkin's lymphoma (NHL).
TLSR: Zevalin and Bexxar are radioactive conjugated antibodies.
EP: Yes, and their biggest problem was Roche's Rituxan (rituximab), a non-radioactive drug that treats NHL really well. That's why the radioactive therapies never got off the ground.
As opposed to Zevalin and Bexxar, the Novelos drugs are not specific for a type of cancer. When examined in preclinical models, 52 out of 54 of those models demonstrated uptake of the company's radioactively labeled targeting vehicle, as opposed to healthy cells, which were largely immune to the uptake of this iodine-131 (I-131) labeled drug. It is also interesting that the company can swap out the I-131 isotope for a lesser or gentler energy-emitting isotope, the 124 version of iodine (I-124), using the same targeting vehicle. That could be a diagnostic agent. We are dealing with a personalized medicine concept here, whereby the patient would be imaged. If the drug is taken up by the lung tumor or the brain tumor, then the same patient could be treated with the same targeting vehicle, but with the much more powerful, I-131 version of the isotope attached to it. I like I-131 because it has been used on its own in thyroid cancer for the last 2025 years, and it works. It gets into the thyroid cancer cells and actually destroys the cells from within.
There is a third leg to this story. If one swaps out the radioactive isotope for a fluorescent one, then this drug could be used as a surgical tool to differentiate between healthy and tumoral tissues. When a surgeon removes a glioblastoma from the brain, or a breast tumor, by shining light on the surgical site, he or she would be able to see where to cut with a safe margin in real time.
Novelos has developed one concept but three different approaches. Actually, all three could coexist in the same setting. I can envision a glioblastoma patient diagnosed with the light version of the company's drug. If a resection is warranted, then the tumor could be resected using the fluorescent version of the molecule. If the resection is not feasible because of the invasiveness of the tumor, then the hot version, the I-131-labeled version, could be applied to treat the patient.
TLSR: Where is it in development?
EP: The company is in phase 1/2 testing in the first two aspects, the imaging and the radiotherapy components. Like Ohr Pharmaceutical, Novelos already has some clinical proof-of-concept because we know that I-131 works in thyroid cancer. If the drug gets into a brain tumor or a pancreatic tumor, we know that I-131 would selectively destroy the tumoral tissue.
TLSR: I know you follow Omeros Corp. (OMER:NASDAQ). Would you speak to that?
EP: Omeros Corp. is a diversified biotechnology and a specialty pharma company under the same roof. The company has two phase 3 assets nearing FDA submission, along with a deep drug pipeline and a discovery engine that has been able to achieve unparalleled success. I would categorize the leading assets as specialty pharma products. They represent an improvement for patient management in the surgical setting. Patients are normally treated with anti-inflammatory drugs and/or painkillers right after surgery. However, inflammation occurs during surgery. Omeros has formulated existing drugs to be applied during surgery via the irrigation solution that is applied normally during procedures. The company has shown, in two phase 3 eye surgery trials, that the concept works: Patients recover faster. A phase 3 trial in the knee surgery setting is expected to be announced this month. I don't think we are dealing with blockbuster drugs here, but if approved, cash flows from these drugs could be reinvested in the company's burgeoning pipeline.
"A solid scientific foundation is a must, a given."
I would also like to mention what I believe is an unprecedented achievement in the field of drug discovery. It pertains to drugs that target G-protein-coupled receptors (GPCRs). GPCRs were favorite targets for drug discovery. About 3040% of all marketed drugs target GPCRs; these include well-known brands such as Claritin, Imitrex, Zantac, Zyprexa, Vicodin and OxyContin. All together these and other drugs in the class address 46 GPCRs. Before Omeros entered the field, there were ~120 so-called orphan GPCRs. Scientists knew that they might be important in various diseases, but no drug leads were developed from them, including at big pharma.
Omeros has developed a universal "cracking" mechanism that yields drug leads for the orphan receptors. Here is the unprecedented part: Omeros has unlocked (or found drug candidates for) 46 of the orphan GPCRs in little over a year. The field was at a standstill for years, but now this relatively small company is ready to supply the pharma world with a treasure trove of drug candidates. The company has initiated business development activities to license most of these assets, with perhaps the exception of a few that they would develop on their own. These programs are preclinicalthey are many years away from the marketbut the sheer number and the unprecedented value (no one has been able to do it), makes me excited about the GPCR platform at Omeros.
Omeros has one last drug moving to clinical development early next year. People aren't usually excited about late preclinical assets, but this one is an exception. Before describing the asset, let me mention Alexion Pharmaceuticals Inc.'s (ALXN:NASDAQ) Soliris (eculizumab), a drug for two ultra-orphan indications. Both indications (paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome) are a result of the malfunction of the immune system's so-called complement arm. The immune system attacks blood components. Both indications are, fortunately, extremely rare. However, Alexion was able to create a market with Soliris, which this year would be worth $1.2B. How? The cost of Soliris is more than $400,000 per patient per year.
Enter Omeros. The company is developing an upstream inhibitor of the complement systemupstream in the biochemical cascade, where Soliris interferes. Based on animal experiments, there could be a number of advantages to the Omeros solution (OMS721), including a much lower dose given as an injection, as opposed to an infusion (Soliris). Furthermore, because of the point of the intervention in the complement cascade, it is thought that patients would not have to use anticoagulants, as they do with the Soliris treatment. The early clinical experiments with OMS721 could indicate whether the Omeros drug would be a serious contender against blockbuster Soliris. We will know within 612 months.
TLSR: I enjoyed this so much. Thank you, Elemer.
EP: Thank you. It was nice meeting you.
Elemer Piros joined Burrill & Co. from Rodman & Renshaw, where he served as a managing director and senior biotechnology analyst since 2002. He has ranked among the top analysts in various surveys, including ranking as the top biotechnology analyst by The Wall Street Journal in 2006 and by the Financial Times in 2010, based on stock portfolio performance. Prior to that, he served as a senior biotechnology analyst at Ladenburg Thalmann, and as a biotechnology research analyst with Spear, Leeds & Kellogg/Goldman Sachs. Before serving as an analyst, Piros spent eight years conducting research in biophysics, biochemistry and molecular biology at Cornell University and the University of California, Los Angeles. He holds a doctorate in neurosciences from UCLA, a bachelor's degree in biology from UCLA, and a bachelor's degree in mathematics and technology from Eotvos Lorand University in Budapest.
Want to read more Life Sciences Report interviews like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see a list of recent interviews with industry analysts and commentators, visit our Streetwise Interviews page.
1) George S. Mack of The Life Sciences Report conducted this interview. He personally and/or his family own shares of the following companies mentioned in this interview: None.
2) The following companies mentioned in the interview are sponsors of The Life Sciences Report: None. Streetwise Reports does not accept stock in exchange for services. Interviews are edited for clarity.
3) Elemer Piros: I personally and/or my family own shares of the following companies mentioned in this interview: None. I personally and/or my family am paid by the following companies mentioned in this interview: None. I was not paid by Streetwise Reports for participating in this story.


text:
"[Shenk] tells engaging stories, lucidly explains complex research and offers fresh insights in the nature of exceptional peformance,,,,such efforts have resulted in a deeply interesting and important book. David Shenk may not be a genius yet, but give him time."– New York Times Book Review
"Inspired…The Genius in All of Us has quietly blown my mind."–Salon
"…a welcome new book…you'll find [Shenk] a fluid, easy writer…The Genius in All of Us is a quick, compelling read."
– The Boston Globe
"Empowering…myth-busting…highly readable…entertaining."
"Intent on burying the concept of inborn genius, Shenk uses the 128 pages of "The Argument" to drive home how mistaken the notion of being genetically destined at birth to be a Mozart or a Michael Jordan is. For genes aren't the inalterable essences that environmental effects merely help out; rather, genes and environment interact to realize a person's potential in a constant and complicated process that Shenk attractively exemplifies through the athletic life of Ted Williams, who began hitting practice at age six and, equally important, never gave it up; also, considered to have magically sharp sight, he tested only high normal upon entering naval aviation—the thing was, he developed himself to, as Ty Cobb said, "see more of the ball than any man alive." En route to the startling revelation that Lamarckism (variation by inheritance, not Darwinian natural selection) has truth in it, after all, Shenk corrects common knowledge about what twin studies and IQ tests really show; clarifies the arguably most misunderstood genetics term, heritable; and scientifically revives faith in not just practice and determination but also parenting and lifestyle as crucial factors, along with genes, in the realization of talents. Since this flies in the face of a century of genetic determinism, Shenk employs the equally engrossing 141 pages of "The Evidence" to cite, quote, paraphrase, and comment upon the sources for virtually every assertion in "The Argument."
—Booklist, starred review
"An inspiring and liberating book. It's a powerful antidote to the genetic determinism rampant in the Age of the Genome, and an instructive guide, grounded in science, to living a more enriching life."
–STEVEN JOHNSON, author of The Invention of Air, Ghost Map, Everything Bad is Good for You, Mind Wide Open, Emergence, and Interface Culture
"This book, both rigorous and accessible, is a close study of the idea of genius, an investigation of popular misconceptions about genetics, and an examination of the American virtue of self-determination. It is written with assurance, insight, clarity, and wit." – ANDREW SOLOMON, author of The Noonday Demon (National Book Award Winner, 2001)
"A great book. David Shenk handily dispels the myth that one must be born a genius. From consistently whacking the ball out of the park to composing ethereal piano sonatas, Shenk convincingly makes the case for the potential genius that lies in all of us." — RUDOLPH E. TANZI, PH.D., Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Director, Genetics and Aging Research Unit, Massachusetts General Hospital
"David Shenk sweeps aside decades of misconceptions about genetics — and shows that by overstating the importance of genes, we've understated the potential of ourselves. This is a persuasive and inspiring book that will make you think anew about your own life and our shared future." — DANIEL H. PINK, author of Drive and A Whole New Mind
"In clear, forceful language, backed up by a boatload of science, David Shenk delivers a message that should be read by every parent, educator, and policy-maker who cares about the future of our children. The Genius in All of Us convincingly debunks the "genes are destiny" argument when it comes to human talent, and will force you to rethink everything from IQ tests and twins studies to child-rearing practices. Shenk's book turns Baby Mozart on his head, and will give pause–a hopeful, empowering pause–to parents who wish to nurture excellence in their children."
— STEPHEN S. HALL, author of Wisdom: From Philosophy to Neuroscience
"David Shenk freshens and transforms a familiar subject to reveal all the interacting forces and factors that make us who we are. Development is a tricky business and Shenk understands this. By focusing his considerable writing talents on this terribly important topic, he has provided parents, policymakers, and educators with a book that will help them cut through the noise and make sense of every child's development."
— MARK. S. BLUMBERG, Ph.D., F. Wendell Miller Professor of Psychology, University of Iowa; editor-in-chief, Behavioral Neuroscience; and author, Freaks of Nature: What Anomalies Tell Us about Development and Evolution
"The importance of David Shenk's book is that he has made accessible to a wide audience the advances in the understanding of how each person develops. I congratulate him." – SIR PATRICK BATESON, FRS, Emeritus Professor of Ethology, Cambridge University; former Biological Secretary of the Royal Society (UK); and co-author, Design For A Life: How Behaviour Develops


text:
Voted the best hostel in France for 2011 by Hostelworld customers!
Vertigo Vieux Port is a newly renovated hostel in Marseille. As for Vertigo Centre that opened three years ago, you can find the feeling of a second home here.
We're located in the Old Port area, walking distance from beaches, bars, clubs, the central market and the famous Notre Dame church.
We offer charming two-, three-, four-, five- and six-bed rooms. All of our dorms are very clean and equipped with comfy wooden bunk beds, private shower and toilet facilities. The five- and six-bed dorms are equipped with two private bathrooms.
Every room in our hostel is carefully designed and decorated by local artists according to the unique character of each room.
Our building was renovated from two typical buildings which makes for a modern cosy atmosphere, while at the same time it has the feel of a typical Marseillean house.
We offer a ton of free amenities, such as breakfast, Wi-Fi, linen, a fully-equipped kitchen with free spices, city maps, personal travel info, use of our travel guidebooks, luggage storage, book swap and a valuables safe at reception – all for free!
Our friendly, caring and multi-lingual staff are here 24hrs a day to answer all your questions. We'll try our best to make you have a memorable stay in our hostel and in Marseille. And of course there's no curfew, no lockout and no stupid rules!
We'll make sure that you feel like you're home here. After you have been either on the road all day, or walking around in the city, you'll be able to relax in our cosy and friendly common areas, have a drink, talk and make friends.
Min rate:
Max rate:
14986 Hostels in Marseille (France)
starting from €
Our team is your service to help you with your booking issues or answer any related questions


text:
"Cristina Rathbone is a fearless journalist, not only because she spent five years talking to women inmates at Framingham, but because she would not let the authorities keep her from telling the close-up truth about the lives of women in prison. This book will alter the way we think about the mothers, daughters, wives, and sisters our society has forgotten."
"The crimes committed by American women do not justify the crimes now being committed against them in our prisons. Cristina Rathbone has written a powerful book about the cruelty of this system, full of eloquence, dark humor, and compassion."
–Eric Schlosser, author of Fast Food Nation
"This is an important, hard-won book, throughout which the deepest meanings of commitment come to bear: the unjust commitment of women to our nation's prisons, the women's commitment to their families and the risks of hope, and, as strikingly, Cristina Rathbone's commitment to her profession and her craft."
–Adrian Nicole LeBlanc, author of Random Family
"A World Apart should be required reading for all Americans, and especially those concerned about gender and justice. Through compelling narratives of inmate lives, interspersed with historical background, Rathbone exposes the high personal and social costs of poverty, violence, and sexual coercion. Beautifully presented, these stories provide both raw and tender accounts of institutional life, documenting as well women's struggles to break the cycle of institutionalization. The contrast between historical episodes of prison reform and the contemporary disaster of women's prisons will sadden and should enrage readers."
–Estelle B. Freedman, Edgar E. Robinson professor of U.S. history, Stanford University, author of Their Sisters' Keepers: Women's Prison Reform in America, 1830—1930


text:
Casey Kasem Reportedly Still Not Buried One Month After Death
A month after legendary radio host Casey Kasem passed away on June 15, his body still remains unburied, according to a publicist for Kasem's daughter.
The Huffington Post reports that a lawyer for one of Kasem's daughters, Kerri Kasem, claims that Casey's remains are still at a funeral home in Tacoma, Wash. The lawyer says that Kerri and her brother and sister from Kasem's first marriage hope to honor his wishes of being buried at Forest Lawn cemetery in Glendale, Calif.
Casey's second wife, Jean Kasem, currently has rights to the body but reportedly has not made any burial arrangements yet.
The rights over Casey's body is the latest in a battle between Casey's children from his first marriage and Jean Kasem. During the last several months of his life, the children -- Kerri, Julie, Mike -- claimed that Jean had been preventing them from seeing their father. Casey had been suffering from advanced Parkinson's disease and dementia.
Casey Kasem hosted the American Top 40 show beginning in 1970 and did his weekly countdown until 2004. He continued to broadcast shows until 2009, when he retired from radio. He was 82 years old when he passed away last month.


text:
Multiple Dates
Drekker Brewing Grains-to-Glass Tour - Supporting the UnPillage Charities
Take part in a guided tour and tasting at Drekker Brewing Company. We'll take you through the entire brewing process from grains to glass. Sampling raw materials, getting an up-close look at the tanks, and finish with a guided tasting session. All tours are hosted by one of the owners/brewers so you'll be able to talk with the guys who've handcrafted all the beers you're tasting. Come join us for this fun, informative, and laid-back craft beer experience. Here are the main details about the tour:
- Guided "Grains-to-Glass" tour with the brewer and a 1/2 pint pour of beer
- Tasting session of 4 beers throughout the tour
- Tour is FREE with a suggested donation to the Drekker UnPillage Charity of the Month
+Tours are limited to 30 guests
+All attendants must be 21 years of age and present a valid ID
+Closed toe shoes are required to participate in the tour
+Please let us know within 48 hours if you need to cancel your reservation


text:
Vanpool Makes Long Distance Commuting Easy
Please visit http://transit.coloradosprings.gov/transportation/public-transportation/alternative-transportation/mountain-metro-rides-vanpool for the most up-to-date information this page is no longer being updated.
Mountain Metro Rides vanpool service is a smart choice for groups of commuters who live and work near each other and travel more than 30 miles each way, to and from work. Passengers share the ride and pay a low monthly fare for a minivan seating up to 7, or a full-size van seating up to 12.
How vanpool works:
- A group of 6 to12 people share a ride to work in a van dedicated to their commute, for a monthly fare based on the mileage and number of passengers in the van.
- Vanpool riders volunteer to drive, track maintenance and submit paperwork.
- Volunteer vanpool drivers must have clean motor vehicle records, receive insurance approvals and sign vanpool agreements.
How to form a vanpool:
- Email co-workers or post notices at work.
- Talk to co-workers about forming a vanpool.
- Post notices in nearby buildings and have those interested contact you.
- Contact the Metro Rides Vanpool Specialist and find out if there are people near your work or home who are on a vanpool waiting list.
Once you have a vanpool group:
- Set up a brief planning meeting to decide on a time and place to meet (see Park-n-Ride locations).
- Choose your drivers and riders (it's easier than it sounds).
- Complete your sign-up forms (both online and printable forms are available).
- Sit back and enjoy the savings - and the ride!


text: You have tickets reserved. You have a limited time to complete your booking before your reservation expires and you will have to start your reservation process again. You can keep an eye on the time remaining in the top right of the page. Cancel Reservation Are you sure you want to cancel your reservation? Ticketing Terms & Conditions | Ticketing FAQs | Ticketing Privacy Policy | My Account | Powered by Oztix


text:
For four months, Kathryn Cohen Allen tormented and threatened her neighbors, railing against interracial dating and against what she believed was a seedy affair.
During the summer of 2011, she took it a step further: concocting an anthrax threat against Florida's two U.S. senators.
Allen filled the envelopes with powder and notes. She filled out the U.S. senators' addresses, then she signed the envelopes with the names and addresses of a black neighbor and a white woman she knew.
Senators Bill Nelson and Marco Rubio received Allen's death threats and cornstarch - used to simulate a deadly anthrax threat - four months after she started her gossip campaign, targeting a black man and a white woman in her home county of Hamilton. She was arrested about a year later.
Allen pleaded guilty Friday in U.S. District Court to sending the letters.
Court documents detailed exactly how she tormented the man and woman:
It started one day in February 2011 in Jasper, a small town north of Live Oak near the Georgia border. That day, the man found a note glued to his truck. The note accused him of sleeping with a married white woman. The note included a threat against him and against his son.
The man and woman were not named in federal court documents.
More letters soon followed. Group text messages went to people around Jasper, claiming the man was sleeping with the woman.
Businesses in Jasper began receiving similar letters, saying who was visiting the man at his home and at what times. The letters described the kind of car the woman drove, what clothes she wore.
The information was accurate. The man was being watched.
The moment he walked into his house, his phone started ringing, but when he answered the caller would hang up. Once he stepped outside, the phone stopped ringing.
Next came invitations to a baby shower for the man and the woman's child, except that there was no child.
The woman's children were sent letters at school. Your mom shouldn't be dating black men, they read.
The state Department of Children and Family Services received a doll and a letter that claimed the man was a child molester.
The woman and her husband received a letter offering them condolences upon the deaths of their children. The children hadn't died.
On Facebook, "Amber Smith," a young busty white woman who had recently graduated from high school and didn't seem to like to wear much beyond a bra, published the black man's address and told people to come at specific times on specific days to watch the affair.
Meanwhile, Allen found herself in luck. She and her husband had won some money from a scratch-off lottery ticket. With the money, they bought a computer and a television. She let the FBI check her computer. The FBI imaging revealed that Allen was behind the Amber Smith account.
Allen, who lived with her husband across the street from the black man, had sent threatening letters filled with cornstarch powder to the tax collector's office, the health department, the jail, the Department of Children and Family Services. She also sent letters to the man and to three other people who weren't identified in the federal documents.
She admitted all of that as part of her plea deal. She still awaits sentencing, and she could face up to 10 years in prison and a fine of up to $500,000. Whether the man and the woman had an affair was not noted in the federal case.
Andrew Pantazi: (904) 359-4310


text:
Schooling for Tomorrow Knowledge Base › Futures Thinking › Practices
'Without this sort of thinking we might have got bogged down by existing realities and could well have ended up simply redesigning a school which was created 30-40 years ago' (FutureSight, UK, 2005).
Education is a relatively new field for futures thinking, which has been more widely applied in energy, environmental, and pension policy.
Schooling for Tomorrow is piloting a series of projects, working with countries to implement a range of initiatives: Futures Thinking Initiatives in Action. Together these experiences demonstrate the diversity of potential educational applications for Futures Thinking.


text:
Here is what will likely be the final update of my class notes from Winter 2013, University of Toronto Condensed Matter Physics course (PHY487H1F), taught by Prof. Stephen Julian.
Official course description: "Introduction to the concepts used in the modern treatment of solids. The student is assumed to be familiar with elementary quantum mechanics. Topics include: bonding in solids, crystal structures, lattice vibrations, free electron model of metals, band structure, thermal properties, magnetism and superconductivity (time permitting)"
This document contains:
• Plain old lecture notes. These mirror what was covered in class, possibly augmented with additional details.
• Personal notes exploring details that were not clear to me from the lectures, or from the texts associated with the lecture material.
• Assigned problems. Like anything else take these as is.
• Some worked problems attempted as course prep, for fun, or for test preparation, or post test reflection.
• Links to Mathematica workbooks associated with this course.
My thanks go to Professor Julian for teaching this course.
NOTE: This v.5 update of these notes is still really big (~18M). Some of my mathematica generated 3D images result in very large pdfs.
Changelog for this update (relative to the first, and second, and third, and the last pre-exam Changelogs).
January 19, 2014 Quadratic Deybe
January 19, 2014 One atom basis phonons in 2D
January 07, 2014 Two body harmonic oscillator in 3D
Figure out a general solution for two interacting harmonic oscillators, then use the result to calculate the matrix required for a 2D two atom diamond lattice with horizontal, vertical and diagonal nearest neighbour coupling.
December 04, 2013 Lecture 24: Superconductivity (cont.)
December 04, 2013 Problem Set 10: Drude conductivity and doped semiconductors.